DCTA vs. IOF, HAYD, WCH, ITX, HDD, BIOM, ESKN, AGM, VRS, and ZED
Should you be buying Directa Plus stock or one of its competitors? The main competitors of Directa Plus include Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Hardide (HDD), Biome Technologies (BIOM), Esken (ESKN), Applied Graphene Materials (AGM), Versarien (VRS), and Zenova Group (ZED). These companies are all part of the "specialty chemicals" industry.
Directa Plus vs. Its Competitors
Directa Plus (LON:DCTA) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.
Iofina has a consensus price target of GBX 37.50, suggesting a potential upside of 34.89%. Given Iofina's stronger consensus rating and higher possible upside, analysts plainly believe Iofina is more favorable than Directa Plus.
Iofina has a net margin of 6.98% compared to Directa Plus' net margin of -48.00%. Iofina's return on equity of 8.00% beat Directa Plus' return on equity.
In the previous week, Iofina had 1 more articles in the media than Directa Plus. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Directa Plus. Directa Plus' average media sentiment score of 0.00 beat Iofina's score of -0.92 indicating that Directa Plus is being referred to more favorably in the media.
Directa Plus has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.
Iofina has higher revenue and earnings than Directa Plus. Directa Plus is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
20.5% of Directa Plus shares are owned by institutional investors. Comparatively, 6.4% of Iofina shares are owned by institutional investors. 57.9% of Directa Plus shares are owned by insiders. Comparatively, 45.1% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Iofina beats Directa Plus on 12 of the 16 factors compared between the two stocks.
Get Directa Plus News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Directa Plus Competitors List
Related Companies and Tools
This page (LON:DCTA) was last updated on 7/21/2025 by MarketBeat.com Staff
